“`html
Hims and Hers Health (HIMS) announced a collaboration with Novo Nordisk (NVO) to introduce weight-loss care treatments involving GLP-1 medications, including Ozempic and Wegovy, to its platform later this month. This announcement comes after a patent infringement lawsuit between the two companies was dismissed, resulting in a notable surge in HIMS shares this week, despite being down nearly 30% year-to-date. Novo Nordisk’s shares have also decreased over 50% in the past year.
Sterling Infrastructure (STRL) reported a significant revenue increase of 50% year-over-year, totaling $756 million, aided by its acquisition of CEC Facilities Group which contributed $129 million. STRL’s backlog risen to $3.0 billion, a 78% increase from the previous year, and 123% growth in its E-Infrastructure segment further underscores its robust performance.
Marvell Technology (MRVL) achieved record net revenues of $2.2 billion in its recent quarterly report, driven by demand in the AI sector. The company expects continued year-over-year growth, bolstered by strong design wins in fiscal 2026, contributing to a recent rise of 11% in its share price.
“`
